SCHEMBL24497690

SCHEMBL24497690

COc1c(NC(=O)OC(C)(C)C)cc(F)cc1-c1cnccn1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 4/20 0.39
CYP17A1 P05093 1/20 0.37
ACVR1B P36896 2/20 0.35
TGFBR1 P36897 2/20 0.35
ACVRL1 P37023 2/20 0.35
NAMPT P43490 1/20 0.35
CHEK1 O14757 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ATR Q13535 1/20 0.34
AAK1 Q2M2I8 1/20 0.34
SYK P43405 1/20 0.33
MAP4K1 Q92918 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
METAP1 P53582 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29686286 1.00 TYK2 (0.39) TYK2CYP17A1ACVR1BTGFBR1ACVRL1
SCHEMBL26116301 0.85 TYK2 (0.41) TYK2CHEK1KDM4EMAPK8MAPK9
SCHEMBL30695857 0.85 TYK2 (0.39) TYK2CYP17A1AAK1
SCHEMBL24498203 0.85 TYK2 (0.39) TYK2CYP17A1AAK1
SCHEMBL24498474 0.82 TYK2 (0.50) TYK2NAMPTKDM4EATRMETAP1
SCHEMBL29686078 0.82 TYK2 (0.50) TYK2NAMPTKDM4EATRMETAP1
SCHEMBL29686569 0.82 AAK1 (0.36) TYK2CYP17A1ACVR1BTGFBR1ACVRL1
SCHEMBL24498541 0.82 TYK2 (0.46) TYK2CYP17A1NAMPTATRMETAP1
SCHEMBL29686848 0.82 TYK2 (0.46) TYK2CYP17A1NAMPTATRMETAP1
SCHEMBL26113625 0.82 TYK2 (0.43) TYK2CYP17A1ATRSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240101548-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD (CN) 2024-03-28 US disclosed
EP-4257587-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shenzhen Chipscreen Biosciences Co., Ltd. (CN) 2023-10-11 EP disclosed
EP-4257587-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shenzhen Chipscreen Biosciences Co., Ltd. (CN) 2023-10-11 EP disclosed
CN-114901656-A Hydroximic acid ester compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2022-08-12 CN disclosed
WO-2022117016-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 深圳微芯生物科技股份有限公司 2022-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101548-A1 HYDROXAMATE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF TYK2, WEE2, WEE1 TYK2 1/4885CYP17A1 563/4885ACVR1B 1121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.